Elegen Competitors or Alternatives

Elegen's top competitors include DNA Script, Twist Bioscience and Ribbon Biolabs.

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Elegen's company profile

Matthew Hill

Founder & CEO

90/100
1 - 25
$35M
$100K - 5M
1
Elegen's Competitor - DNA Script logo

Marc Montserrat

CEO

- -
100 - 250
$317.2M
$25M - 100M
2
Elegen's Competitor - Twist Bioscience logo

Emily Leproust

Co-Founder & CEO

96/100
990
$1.1B
$330.2M
3
Elegen's Competitor - Ribbon Biolabs logo

Jodi Barrientos

Interim-CEO

90/100
1 - 25
$20.1M
$100K - 5M
4
Elegen's Competitor - Evonetix logo

Colin McCracken

CEO

90/100
25 - 100
$68M
$5M - 25M
5
Elegen's Competitor - IDT logo

Demaris Mills

President

88/100
1,000 - 5,000
- -
$100M - 500M

Elegen VS DNA Script

DNA Script is perceived as one of Elegen's biggest rivals. DNA Script was founded in 2014, and is headquartered in Le Kremlin-Bicetre, Île-de-France. Like Elegen, DNA Script also competes in the Pharmaceuticals & Biotechnology space. DNA Script generates $31.9M more revenue vs. Elegen.

Elegen VS Twist Bioscience

Twist Bioscience is a top competitor of Elegen. Twist Bioscience is a Public company that was founded in 2013 in South San Francisco, California. Like Elegen, Twist Bioscience also works within the Pharmaceuticals & Biotechnology sector. Compared to Elegen, Twist Bioscience has 970 more employees.

Elegen VS Ribbon Biolabs

Ribbon Biolabs is Elegen's #3 rival. Ribbon Biolabs is headquartered in Vienna, Vienna, and was founded in 2018. Ribbon Biolabs operates in the Biotechnology industry. Ribbon Biolabs generates 100% the revenue of Elegen.

Frequently Asked Questions about Elegen

  1. Who are Elegen's top competitors?

    Elegen's top 3 competitors are DNA Script, Twist Bioscience, Ribbon Biolabs.
  2. Who is similar to Elegen?

    DNA Script is the most similar to Elegen. Twist Bioscience and Ribbon Biolabs are also similar to Elegen.
  1. Are Elegen and DNA Script competitors?

    Yes, DNA Script is one of Elegen’s top competitors.